Molecular States Underlying Androgen Receptor Activation: A Framework for Therapeutics Targeting Androgen Signaling in Prostate Cancer

被引:118
作者
Nelson, Peter S. [1 ]
机构
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
关键词
RESPONSIVE GENES; CASTRATION; THERAPY; ANTIANDROGEN; PROGRESSION; ABIRATERONE; MECHANISMS; EXPRESSION; RESISTANCE; CARCINOMA;
D O I
10.1200/JCO.2011.39.1300
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:644 / 646
页数:3
相关论文
共 32 条
[1]   Regression of Castrate-Recurrent Prostate Cancer by a Small-Molecule Inhibitor of the Amino-Terminus Domain of the Androgen Receptor [J].
Andersen, Raymond J. ;
Mawji, Nasrin R. ;
Wang, Jun ;
Wang, Gang ;
Haile, Simon ;
Myung, Jae-Kyung ;
Watt, Kate ;
Tam, Teresa ;
Yang, Yu Chi ;
Banuelos, Carmen A. ;
Williams, David E. ;
McEwan, Iain J. ;
Wang, Yuzhou ;
Sadar, Marianne D. .
CANCER CELL, 2010, 17 (06) :535-546
[2]   Intratumoral De Novo Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors [J].
Cai, Changmeng ;
Chen, Sen ;
Ng, Patrick ;
Bubley, Glenn J. ;
Nelson, Peter S. ;
Mostaghel, Elahe A. ;
Marck, Brett ;
Matsumoto, Alvin M. ;
Simon, Nicholas I. ;
Wang, Hongyun ;
Chen, Shaoyong ;
Balk, Steven P. .
CANCER RESEARCH, 2011, 71 (20) :6503-6513
[3]   Maximum androgen blockade in advanced prostate cancer: A meta-analysis of published randomized controlled trials using nonsteroidal antiandrogens [J].
Caubet, JF ;
Tosteson, TD ;
Dong, EW ;
Naylon, EM ;
Whiting, GW ;
Ernstoff, MS ;
Ross, SD .
UROLOGY, 1997, 49 (01) :71-78
[4]   Molecular determinants of resistance to antiandrogen therapy [J].
Chen, CD ;
Welsbie, DS ;
Tran, C ;
Baek, SH ;
Chen, R ;
Vessella, R ;
Rosenfeld, MG ;
Sawyers, CL .
NATURE MEDICINE, 2004, 10 (01) :33-39
[5]   Short hairpin RNA knockdown of the androgen receptor attenuates ligand-independent activation and delays tumor progression [J].
Cheng, Helen ;
Snoek, Rob ;
Ghaidi, Fariba ;
Cox, Michael E. ;
Rennie, Paul S. .
CANCER RESEARCH, 2006, 66 (21) :10613-10620
[6]   Abiraterone and Increased Survival in Metastatic Prostate Cancer [J].
De Bono, Johann S. ;
Logothetis, Christopher J. ;
Molina, Arturo ;
Fizazi, Karim ;
North, Scott ;
Chu, Luis ;
Chi, Kim N. ;
Jones, Robert J. ;
Goodman, Oscar B., Jr. ;
Saad, Fred ;
Staffurth, John N. ;
Mainwaring, Paul ;
Harland, Stephen ;
Flaig, Thomas W. ;
Hutson, Thomas E. ;
Cheng, Tina ;
Patterson, Helen ;
Hainsworth, John D. ;
Ryan, Charles J. ;
Sternberg, Cora N. ;
Ellard, Susan L. ;
Flechon, Aude ;
Saleh, Mansoor ;
Scholz, Mark ;
Efstathiou, Eleni ;
Zivi, Andrea ;
Bianchini, Diletta ;
Loriot, Yohann ;
Chieffo, Nicole ;
Thian Kheoh ;
Haqq, Christopher M. ;
Scher, Howard I. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (21) :1995-2005
[7]   Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance [J].
Dehm, Scott M. ;
Schmidt, Lucy J. ;
Heemers, Hannelore V. ;
Vessella, Robert L. ;
Tindall, Donald J. .
CANCER RESEARCH, 2008, 68 (13) :5469-5477
[8]   Effects of Abiraterone Acetate on Androgen Signaling in Castrate-Resistant Prostate Cancer in Bone [J].
Efstathiou, Eleni ;
Titus, Mark ;
Tsavachidou, Dimitra ;
Tzelepi, Vassiliki ;
Wen, Sijin ;
Anh Hoang ;
Molina, Arturo ;
Chieffo, Nicole ;
Smith, Lisa A. ;
Karlou, Maria ;
Troncoso, Patricia ;
Logothetis, Christopher J. .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (06) :637-643
[9]   The development of androgen-independent prostate cancer [J].
Feldman, BJ ;
Feldman, D .
NATURE REVIEWS CANCER, 2001, 1 (01) :34-45
[10]   Lineage dependency and lineage-survival oncogenes in human cancer [J].
Garraway, Levi A. ;
Sellers, William R. .
NATURE REVIEWS CANCER, 2006, 6 (08) :593-602